Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-Cholesterol levels during psychopharmacological treatment - A cross-sectional naturalistic study

Psychiatry Research

Volumn 197, Issue 3, 2012, Pages 327-336

  Athanasiu, Lavinia ^a,b,c   Brown, Andrew A ^a   Birkenaes, Astrid B ^a   Mattingsdal, Morten ^c,d   Agartz, Ingrid ^a,e   Melle, Ingrid ^a,c   Steen, Vidar M ^f,g   Andreassen, Ole A ^a,c   Djurovic, Srdjan ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Department of Medical Genetics ^*  (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Sørlandet Hospital   (Norway)

^e DIAKONHJEMMET HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

GWAS; Major psychiatric disorders; Pharmacogenomics

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; ARIPIPRAZOLE; C REACTIVE PROTEIN; CITALOPRAM; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMOTRIGINE; LEVOMEPROMAZINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE 16; METHYLPHENIDATE; MIANSERIN; MIRTAZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTINDOLE; SERTRALINE; TOPIRAMATE; TRIACYLGLYCEROL; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; AGED; ALLELE; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 12Q; CHROMOSOME 8Q; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; ETHNIC GROUP; GENE; GENE INTERACTION; GENE LOCATION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC PARAMETERS; MMP16 GENE; MOLECULAR MECHANICS; NATURALISTIC INQUIRY; NORWEGIAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SIDE EFFECT; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART RATE; HUMANS; MALE; MATRIX METALLOPROTEINASE 16; MENTAL DISORDERS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84865105363     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.12.036     Document Type: Article

References (45)

1. Adkins D.E., Aberg K., McClay J.L., Bukszar J., Zhao Z., Jia P., Stroup T.S., Perkins D., McEvoy J.P., Lieberman J.A., Sullivan P.F., van den Oord E.J. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Molecular Psychiatry 2010, 321-332.
2. Andersohn F., Schade R., Suissa S., Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. The American Journal of Psychiatry 2009, 166:591-598.
3. Athanasiu L., Mattingsdal M., Kahler A.K., Brown A., Gustafsson O., Agartz I., Giegling I., Muglia P., Cichon S., Rietschel M., Pietilainen O.P., Peltonen L., Bramon E., Collier D., Clair D.S., Sigurdsson E., Petursson H., Rujescu D., Melle I., Steen V.M., Djurovic S., Andreassen O.A. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. Journal of Psychiatric Research 2010, 748-753.
4. Aulchenko Y.S., Ripatti S., Lindqvist I., Boomsma D., Heid I.M., Pramstaller P.P., Penninx B.W., Janssens A.C., Wilson J.F., Spector T., Martin N.G., Pedersen N.L., Kyvik K.O., Kaprio J., Hofman A., Freimer N.B., Jarvelin M.R., Gyllensten U., Campbell H., Rudan I., Johansson A., Marroni F., Hayward C., Vitart V., Jonasson I., Pattaro C., Wright A., Hastie N., Pichler I., Hicks A.A., Falchi M., Willemsen G., Hottenga J.J., DE Geus E.J., Montgomery G.W., Whitfield J., Magnusson P., Saharinen J., Perola M., Silander K., Isaacs A., Sijbrands E.J., Uitterlinden A.G., Witteman J.C., Oostra B.A., Elliott P., Ruokonen A., Sabatti C., Gieger C., Meitinger T., Kronenberg F., Doring A., Wichmann H.E., Smit J.H., McCarthy M.I., van Duijn C.M., Peltonen L. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nature Genetics 2009, 41:47-55.
5. Birkenaes A.B., Birkeland K.I., Engh J.A., Faerden A., Jonsdottir H., Ringen P.A., Friis S., Opjordsmoen S., Andreassen O.A. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. Journal of Clinical Psychopharmacology 2008, 28:132-137.
6. Birkenaes A.B., Birkeland K.I., Friis S., Opjordsmoen S., Andreassen O.A. Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions. Journal of Clinical Psychopharmacology 2009, 29:109-116.
7. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006, 3:A42.
8. Comuzzie A.G., Hixson J.E., Almasy L., Mitchell B.D., Mahaney M.C., Dyer T.D., Stern M.P., Maccluer J.W., Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nature Genetetics 1997, 15:273-276.
9. Correll C.U., Schenk E.M. Tardive dyskinesia and new antipsychotics. Current Opinion in Psychiatry 2008, 21:151-156.
10. Djurovic S., Gustafsson O., Mattingsdal M., Athanasiu L., Bjella T., Tesli M., Agartz I., Lorentzen S., Melle I., Morken G., Andreassen O.A. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. Journal of Affective Disorders 2010, 126:312-316.
11. Eijgelsheim M., Newton-Cheh C., Sotoodehnia N., de Bakker P.I., Muller M., Morrison A.C., Smith A.V., Isaacs A., Sanna S., Dorr M., Navarro P., Fuchsberger C., Nolte I.M., DE Geus E.J., Estrada K., Hwang S.J., Bis J.C., Ruckert I.M., Alonso A., Launer L.J., Hottenga J.J., Rivadeneira F., Noseworthy P.A., Rice K.M., Perz S., Arking D.E., Spector T.D., Kors J.A., Aulchenko Y.S., Tarasov K.V., Homuth G., Wild S.H., Marroni F., Gieger C., Licht C.M., Prineas R.J., Hofman A., Rotter J.I., Hicks A.A., Ernst F., Najjar S.S., Wright A.F., Peters A., Fox E.R., Oostra B.A., Kroemer H.K., Couper D., Volzke H., Campbell H., Meitinger T., Uda M., Witteman J.C., Psaty B.M., Wichmann H.E., Harris T.B., Kaab S., Siscovick D.S., Jamshidi Y., Uitterlinden A.G., Folsom A.R., Larson M.G., Wilson J.F., Penninx B.W., Snieder H., Pramstaller P.P., van Duijn C.M., Lakatta E.G., Felix S.B., Gudnason V., Pfeufer A., Heckbert S.R., Stricker B.H., Boerwinkle E., O'Donnell C.J. Genome-wide association analysis identifies multiple loci related to resting heart rate. Human Molecular Genetics 2010, 19:3885-3894.
12. Finck B.N., Johnson R.W. Tumor necrosis factor (TNF)-alpha induces leptin production through the p55 TNF receptor. American Journal of Physiology. Regulatory, Integrative and Comperative Physiology 2000, 278:R537-R543.
13. Fox C.S., Heard-Costa N., Cupples L.A., Dupuis J., Vasan R.S., Atwood L.D. Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project. BMC Medical Genetics 2007, 8(Suppl. 1):S18.
14. Jonsdottir H., Opjordsmoen S., Birkenaes A.B., Engh J.A., Ringen P.A., Vaskinn A., Aamo TO, Friis S., Andreassen O.A. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. Journal of Clinical Psychopharmacology 2010, 30:169-175.
15. Kathiresan S., Melander O., Guiducci C., Surti A., Burtt N.P., Rieder M.J., Cooper G.M., Roos C., Voight B.F., Havulinna A.S., Wahlstrand B., Hedner T., Corella D., Tai E.S., Ordovas J.M., Berglund G., Vartiainen E., Jousilahti P., Hedblad B., Taskinen M.R., Newton-Cheh C., Salomaa V., Peltonen L., Groop L., Altshuler D.M., Orho-Melander M. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genetics 2008, 40:189-197.
16. Kreisberg R.A. Diabetic dyslipidemia. The American Journal of Cardiology 1998, 82:67U-73U.
17. Krentz A.J. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2003, 5(Suppl 1):S19-S27.
18. LeHellard S., Theisen F.M., Haberhausen M., Raeder M.B., Ferno J., Gebhardt S., Hinney A., Remschmidt H., Krieg J.C., Mehler-Wex C., Nothen M.M., Hebebrand J., Steen V.M. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?. Molecular Psychiatry 2009, 14:308-317.
19. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41.
20. Levy D., Ehret G.B., Rice K., Verwoert G.C., Launer L.J., Dehghan A., Glazer N.L., Morrison A.C., Johnson A.D., Aspelund T., Aulchenko Y., Lumley T., Kottgen A., Vasan R.S., Rivadeneira F., Eiriksdottir G., Guo X., Arking D.E., Mitchell G.F., Mattace-Raso F.U., Smith A.V., Taylor K., Scharpf R.B., Hwang S.J., Sijbrands E.J., Bis J., Harris T.B., Ganesh S.K., O'Donnell C.J., Hofman A., Rotter J.I., Coresh J., Benjamin E.J., Uitterlinden A.G., Heiss G., Fox C.S., Witteman J.C., Boerwinkle E., Wang T.J., Gudnason V., Larson M.G., Chakravarti A., Psaty B.M., van Duijn C.M. Genome-wide association study of blood pressure and hypertension. Nature Genetics 2009, 41:677-687.
21. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine 2005, 353:1209-1223.
22. Ma L., Yang J., Runesha H.B., Tanaka T., Ferrucci L., Bandinelli S., Da Y. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data. BMC Medical Genetics 2010, (11):55.
23. Meyer J.M., Davis V.G., Goff D.C., McEvoy J.P., Nasrallah H.A., Davis S.M., Rosenheck R.A., Daumit G.L., Hsiao J., Swartz M.S., Stroup T.S., Lieberman J.A. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophrenia Research 2008, 101:273-286.
24. Meyer J.M., Koro C.E. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophrenia Research 2004, 70:1-17.
25. Nagase H., Woessner J.F. Matrix metalloproteinases. The Journal of Biological Chemistry 1999, 274:21491-21494.
26. Newton-Cheh C., Guo C.Y., Wang T.J., O'Donnell C.J., Levy D., Larson M.G. Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study. BMC Medical Genetics 2007, 8(Suppl. 1):S7.
27. Newton-Cheh C., Johnson T., Gateva V., Tobin M.D., Bochud M., Coin L., Najjar S.S., Zhao J.H., Heath S.C., Eyheramendy S., Papadakis K., Voight B.F., Scott L.J., Zhang F., Farrall M., Tanaka T., Wallace C., Chambers J.C., Khaw K.T., Nilsson P., van der Harst P., Polidoro S., Grobbee D.E., Onland-Moret N.C., Bots M.L., Wain L.V., Elliott K.S., Teumer A., Luan J., Lucas G., Kuusisto J., Burton P.R., Hadley D., McArdle W.L., Brown M., Dominiczak A., Newhouse S.J., Samani N.J., Webster J., Zeggini E., Beckmann J.S., Bergmann S., Lim N., Song K., Vollenweider P., Waeber G., Waterworth D.M., Yuan X., Groop L., Orho-Melander M., Allione A., Di G.A., Guarrera S., Panico S., Ricceri F., Romanazzi V., Sacerdote C., Vineis P., Barroso I., Sandhu M.S., Luben R.N., Crawford G.J., Jousilahti P., Perola M., Boehnke M., Bonnycastle L.L., Collins F.S., Jackson A.U., Mohlke K.L., Stringham H.M., Valle T.T., Willer C.J., Bergman R.N., Morken M.A., Doring A., Gieger C., Illig T., Meitinger T., Org E., Pfeufer A., Wichmann H.E., Kathiresan S., Marrugat J., O'Donnell C.J., Schwartz S.M., Siscovick D.S., Subirana I., Freimer N.B., Hartikainen A.L., McCarthy M.I., O'Reilly P.F., Peltonen L., Pouta A., de Jong P.E., Snieder H., van Gilst W.H., Clarke R., Goel A., Hamsten A., Peden J.F., Seedorf U., Syvanen A.C., Tognoni G., Lakatta E.G., Sanna S., Scheet P., Schlessinger D., Scuteri A., Dorr M., Ernst F., Felix S.B., Homuth G., Lorbeer R., Reffelmann T., Rettig R., Volker U., Galan P., Gut I.G., Hercberg S., Lathrop G.M., Zelenika D., Deloukas P., Soranzo N., Williams F.M., Zhai G., Salomaa V., Laakso M., Elosua R., Forouhi N.G., Volzke H., Uiterwaal C.S., van der Schouw Y.T., Numans M.E., Matullo G., Navis G., Berglund G., Bingham S.A., Kooner J.S., Connell J.M., Bandinelli S., Ferrucci L., Watkins H., Spector T.D., Tuomilehto J., Altshuler D., Strachan D.P., Laan M., Meneton P., Wareham N.J., Uda M., Jarvelin M.R., Mooser V., Melander O., Loos R.J., Elliott P., Abecasis G.R., Caulfield M., Munroe P.B. Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics 2009, 41:666-676.
28. Pruim R.J., Welch R.P., Sanna S., Teslovich T.M., Chines P.S., Gliedt T.P., Boehnke M., Abecasis G.R., Willer C.J. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010, 26:2336-2337.
29. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
30. Development Core Team R. R: a Language an Environment for Statistical Computing. R Foundation for Statistical Computing 2008.
31. Ray W.A., Chung C.P., Murray K.T., Hall K., Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. The New England Journal of Medicine 2009, 360:225-235.
32. Reynolds G.P., Zhang Z.J., Zhang X.B. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002, 359:2086-2087.
33. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St C.D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De H.M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de H.L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van O.J., van W.R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011, 43:969-976.
34. Speliotes E.K., Willer C.J., Berndt S.I., Monda K.L., Thorleifsson G., Jackson A.U., Allen H.L., Lindgren C.M., Luan J., Magi R., Randall J.C., Vedantam S., Winkler T.W., Qi L., Workalemahu T., Heid I.M., Steinthorsdottir V., Stringham H.M., Weedon M.N., Wheeler E., Wood A.R., Ferreira T., Weyant R.J., Segre A.V., Estrada K., Liang L., Nemesh J., Park J.H., Gustafsson S., Kilpelainen TO, Yang J., Bouatia-Naji N., Esko T., Feitosa M.F., Kutalik Z., Mangino M., Raychaudhuri S., Scherag A., Smith A.V., Welch R., Zhao J.H., Aben K.K., Absher D.M., Amin N., Dixon A.L., Fisher E., Glazer N.L., Goddard M.E., Heard-Costa N.L., Hoesel V., Hottenga J.J., Johansson A., Johnson T., Ketkar S., Lamina C., Li S., Moffatt M.F., Myers R.H., Narisu N., Perry J.R., Peters M.J., Preuss M., Ripatti S., Rivadeneira F., Sandholt C., Scott L.J., Timpson N.J., Tyrer J.P., van W.S., Watanabe R.M., White C.C., Wiklund F., Barlassina C., Chasman D.I., Cooper M.N., Jansson J.O., Lawrence R.W., Pellikka N., Prokopenko I., Shi J., Thiering E., Alavere H., Alibrandi M.T., Almgren P., Arnold A.M., Aspelund T., Atwood L.D., Balkau B., Balmforth A.J., Bennett A.J., Ben-Shlomo Y., Bergman R.N., Bergmann S., Biebermann H., Blakemore A.I., Boes T., Bonnycastle L.L., Bornstein S.R., Brown M.J., Buchanan T.A., Busonero F., Campbell H., Cappuccio F.P., Cavalcanti-Proenca C., Chen Y.D., Chen C.M., Chines P.S., Clarke R., Coin L., Connell J., Day I.N., Heijer M., Duan J., Ebrahim S., Elliott P., Elosua R., Eiriksdottir G., Erdos M.R., Eriksson J.G., Facheris M.F., Felix S.B., Fischer-Posovszky P., Folsom A.R., Friedrich N., Freimer N.B., Fu M., Gaget S., Gejman P.V., Geus E.J., Gieger C., Gjesing A.P., Goel A., Goyette P., Grallert H., Grassler J., Greenawalt D.M., Groves C.J., Gudnason V., Guiducci C., Hartikainen A.L., Hassanali N., Hall A.S., Havulinna A.S., Hayward C., Heath A.C., Hengstenberg C., Hicks A.A., Hinney A., Hofman A., Homuth G., Hui J., Igl W., Iribarren C., Isomaa B., Jacobs K.B., Jarick I., Jewell E., John U., Jorgensen T., Jousilahti P., Jula A., Kaakinen M., Kajantie E., Kaplan L.M., Kathiresan S., Kettunen J., Kinnunen L., Knowles J.W., Kolcic I., Konig I.R., Koskinen S., Kovacs P., Kuusisto J., Kraft P., Kvaloy K., Laitinen J., Lantieri O., Lanzani C., Launer L.J., Lecoeur C., Lehtimaki T., Lettre G., Liu J., Lokki M.L., Lorentzon M., Luben R.N., Ludwig B., Manunta P., Marek D., Marre M., Martin N.G., McArdle W.L., McCarthy A., McKnight B., Meitinger T., Melander O., Meyre D., Midthjell K., Montgomery G.W., Morken M.A., Morris A.P., Mulic R., Ngwa J.S., Nelis M., Neville M.J., Nyholt D.R., O'Donnell C.J., O'Rahilly S., Ong K.K., Oostra B., Pare G., Parker A.N., Perola M., Pichler I., Pietilainen K.H., Platou C.G., Polasek O., Pouta A., Rafelt S., Raitakari O., Rayner N.W., Ridderstrale M., Rief W., Ruokonen A., Robertson N.R., Rzehak P., Salomaa V., Sanders A.R., Sandhu M.S., Sanna S., Saramies J., Savolainen M.J., Scherag S., Schipf S., Schreiber S., Schunkert H., Silander K., Sinisalo J., Siscovick D.S., Smit J.H., Soranzo N., Sovio U., Stephens J., Surakka I., Swift A.J., Tammesoo M.L., Tardif J.C., Teder-Laving M., Teslovich T.M., Thompson J.R., Thomson B., Tonjes A., Tuomi T., van Meurs J.B., van Ommen G.J. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 2010, 42:937-948.
35. Theisen F.M., Gebhardt S., Haberhausen M., Heinzel-Gutenbrunner M., Wehmeier P.M., Krieg J.C., Kuhnau W., Schmidtke J., Remschmidt H., Hebebrand J. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatric Genetics 2005, 15:285-289.
36. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., Styrkarsdottir U., Gretarsdottir S., Thorlacius S., Jonsdottir I., Jonsdottir T., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Jonsson F., Borch-Johnsen K., Hansen T., Andersen G., Jorgensen T., Lauritzen T., Aben K.K., Verbeek A.L., Roeleveld N., Kampman E., Yanek L.R., Becker L.C., Tryggvadottir L., Rafnar T., Becker D.M., Gulcher J., Kiemeney L.A., Pedersen O., Kong A., Thorsteinsdottir U., Stefansson K. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genetics 2009, 41:18-24.
37. Tiihonen J., Lonnqvist J., Wahlbeck K., Klaukka T., Niskanen L., Tanskanen A., Haukka J., 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) Lancet 2009, 374:620-627.
38. Van Der Kallen C.J., Cantor R.M., Van Greevenbroek M.M., Geurts J.M., Bouwman F.G., Aouizerat B.E., Allayee H., Buurman W.A., Lusis A.J., Rotter J.I., de Bruin T.W. Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A. International Journal of Obesity and Related Metabolic Disorders: journal of the International Association for the Study of Obesity 2000, 24:1381-1391.
39. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., Zeggini E., Huth C., Aulchenko Y.S., Thorleifsson G., McCulloch L.J., Ferreira T., Grallert H., Amin N., Wu G., Willer C.J., Raychaudhuri S., McCarroll S.A., Langenberg C., Hofmann O.M., Dupuis J., Qi L., Segre A.V., van H.M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A.J., Blagieva R., Boerwinkle E., Bonnycastle L.L., Bengtsson B.K., Bravenboer B., Bumpstead S., Burtt N.P., Charpentier G., Chines P.S., Cornelis M., Couper D.J., Crawford G., Doney A.S., Elliott K.S., Elliott A.L., Erdos M.R., Fox C.S., Franklin C.S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C.J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A.U., Johnson P.R., Jorgensen T., Kao W.H., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C.M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M.A., Narisu N., Nilsson P., Owen K.R., Payne F., Perry J.R., Petersen A.K., Platou C., Proenca C., Prokopenko I., Rathmann W., Rayner N.W., Robertson N.R., Rocheleau G., Roden M., Sampson M.J., Saxena R., Shields B.M., Shrader P., Sigurdsson G., Sparso T., Strassburger K., Stringham H.M., Sun Q., Swift A.J., Thorand B., Tichet J., Tuomi T., van Dam R.M., van Haeften T.W., van H.T., van Vliet-Ostaptchouk J.V., Walters G.B., Weedon M.N., Wijmenga C., Witteman J., Bergman R.N., Cauchi S., Collins F.S., Gloyn A.L., Gyllensten U., Hansen T., Hide W.A., Hitman G.A., Hofman A., Hunter D.J., Hveem K., Laakso M., Mohlke K.L., Morris A.D., Palmer C.N., Pramstaller P.P., Rudan I., Sijbrands E., Stein L.D., Tuomilehto J., Uitterlinden A., Walker M., Wareham N.J., Watanabe R.M., Abecasis G.R., Boehm B.O., Campbell H., Daly M.J., Hattersley A.T., Hu F.B., Meigs J.B., Pankow J.S., Pedersen O., Wichmann H.E., Barroso I., Florez J.C., Frayling T.M., Groop L., Sladek R., Thorsteinsdottir U., Wilson J.F., Illig T., Froguel P., van Duijn C.M., Stefansson K., Altshuler D., Boehnke M., McCarthy M.I. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 2010, 42:579-589.
40. Wallace C., Newhouse S.J., Braund P., Zhang F., Tobin M., Falchi M., Ahmadi K., Dobson R.J., Marcano A.C., Hajat C., Burton P., Deloukas P., Brown M., Connell J.M., Dominiczak A., Lathrop G.M., Webster J., Farrall M., Spector T., Samani N.J., Caulfield M.J., Munroe P.B. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. American Journal of Human Genetics 2008, 82:139-149.
41. Waterworth D.M., Ricketts S.L., Song K., Chen L., Zhao J.H., Ripatti S., Aulchenko Y.S., Zhang W., Yuan X., Lim N., Luan J., Ashford S., Wheeler E., Young E.H., Hadley D., Thompson J.R., Braund P.S., Johnson T., Struchalin M., Surakka I., Luben R., Khaw K.T., Rodwell S.A., Loos R.J., Boekholdt S.M., Inouye M., Deloukas P., Elliott P., Schlessinger D., Sanna S., Scuteri A., Jackson A., Mohlke K.L., Tuomilehto J., Roberts R., Stewart A., Kesaniemi Y.A., Mahley R.W., Grundy S.M., McArdle W., Cardon L., Waeber G., Vollenweider P., Chambers J.C., Boehnke M., Abecasis G.R., Salomaa V., Jarvelin M.R., Ruokonen A., Barroso I., Epstein S.E., Hakonarson H.H., Rader D.J., Reilly M.P., Witteman J.C., Hall A.S., Samani N.J., Strachan D.P., Barter P., van Duijn C.M., Kooner J.S., Peltonen L., Wareham N.J., McPherson R., Mooser V., Sandhu M.S. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biolpgy 2010, 30:2264-2276.
42. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., Berndt S.I., Elliott A.L., Jackson A.U., Lamina C., Lettre G., Lim N., Lyon H.N., McCarroll S.A., Papadakis K., Qi L., Randall J.C., Roccasecca R.M., Sanna S., Scheet P., Weedon M.N., Wheeler E., Zhao J.H., Jacobs L.C., Prokopenko I., Soranzo N., Tanaka T., Timpson N.J., Almgren P., Bennett A., Bergman R.N., Bingham S.A., Bonnycastle L.L., Brown M., Burtt N.P., Chines P., Coin L., Collins F.S., Connell J.M., Cooper C., Smith G.D., Dennison E.M., Deodhar P., Elliott P., Erdos M.R., Estrada K., Evans D.M., Gianniny L., Gieger C., Gillson C.J., Guiducci C., Hackett R., Hadley D., Hall A.S., Havulinna A.S., Hebebrand J., Hofman A., Isomaa B., Jacobs K.B., Johnson T., Jousilahti P., Jovanovic Z., Khaw K.T., Kraft P., Kuokkanen M., Kuusisto J., Laitinen J., Lakatta E.G., Luan J., Luben R.N., Mangino M., McArdle W.L., Meitinger T., Mulas A., Munroe P.B., Narisu N., Ness A.R., Northstone K., O'Rahilly S., Purmann C., Rees M.G., Ridderstrale M., Ring S.M., Rivadeneira F., Ruokonen A., Sandhu M.S., Saramies J., Scott L.J., Scuteri A., Silander K., Sims M.A., Song K., Stephens J., Stevens S., Stringham H.M., Tung Y.C., Valle T.T., van Duijn C.M., Vimaleswaran K.S., Vollenweider P., Waeber G., Wallace C., Watanabe R.M., Waterworth D.M., Watkins N., Witteman J.C., Zeggini E., Zhai G., Zillikens M.C., Altshuler D., Caulfield M.J., Chanock S.J., Farooqi I.S., Ferrucci L., Guralnik J.M., Hattersley A.T., Hu F.B., Jarvelin M.R., Laakso M., Mooser V., Ong K.K., Ouwehand W.H., Salomaa V., Samani N.J., Spector T.D., Tuomi T., Tuomilehto J., Uda M., Uitterlinden A.G., Wareham N.J., Deloukas P., Frayling T.M., Groop L.C., Hayes R.B., Hunter D.J., Mohlke K.L., Peltonen L., Schlessinger D., Strachan D.P., Wichmann H.E., McCarthy M.I., Boehnke M., Barroso I., Abecasis G.R., Hirschhorn J.N. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics 2009, 41:25-34.
43. Yamaguchi M., Murakami T., Tomimatsu T., Nishio Y., Mitsuda N., Kanzaki T., Kurachi H., Shima K., Aono T., Murata Y. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochemical and Biophysical Research Communications 1998, 244:30-34.
44. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., de Bakker P.I., Abecasis G.R., Almgren P., Andersen G., Ardlie K., Bostrom K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jorgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbaek A., Shields B., Sjogren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 2008, 40:638-645.
45. Zimmermann U., Kraus T., Himmerich H., Schuld A., Pollmacher T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. Journal of Psychiatric Research 2003, 37:193-220.